These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7992211)

  • 21. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
    Chandra H; Yarzebski J; Goldberg RJ; Savageau J; Singleton C; Gurwitz JH; Gore JM
    Arch Intern Med; 1997 Apr; 157(7):741-6. PubMed ID: 9125005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Systemic thrombolysis with APSAC in a young adult with healthy coronary vessels].
    Mongiat C; Sforza G; Marchese D
    Minerva Anestesiol; 1991 Dec; 57(12):1656. PubMed ID: 1795804
    [No Abstract]   [Full Text] [Related]  

  • 24. The cost-effectiveness of thrombolytic therapy following acute myocardial infarction.
    Fenn P; Gray AM; McGuire A
    Br J Clin Pract; 1991; 45(3):181-4. PubMed ID: 1805915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteplase and anistreplase in acute myocardial infarction.
    Drug Ther Bull; 1989 Dec; 27(26):101-3. PubMed ID: 2519323
    [No Abstract]   [Full Text] [Related]  

  • 26. Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarction.
    Le SP; Chatterjee K; Wolfe CL
    Am Heart J; 1992 May; 123(5):1368-9. PubMed ID: 1575153
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypersensitivity vasculitis after thrombolytic therapy with APSAC (anisoylated plasminogen streptokinase activator complex). Presentation of a clinical case and review of the literature].
    Gianni R; Benucci M; Santoro E; Nenci G; Baruffi MC; Cappelletti C
    Ann Ital Med Int; 1994; 9(2):105-6. PubMed ID: 7917762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The comparative characterization of different forms of myocardial infarction at a 30-year interval].
    Udaĭdullaeva VU; Magrupov BA
    Arkh Patol; 2010; 72(2):15-21. PubMed ID: 20698310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
    Hoffmann JJ; Bonnier JJ; Melman PG; Bartholomeus I
    Am J Cardiol; 1993 Jan; 71(1):14-8. PubMed ID: 8420229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of APSAC in the treatment of acute myocardial infarction.
    Machraoui A; Jäger D; Barmeyer J; Armbrecht J
    Eur Heart J; 1992 Jun; 13(6):818-23. PubMed ID: 1623874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths.
    Hansen DA; Jürgensen HJ; Pedersen-Bjergaard O
    Acta Med Scand Suppl; 1984; 680():50-8. PubMed ID: 6375281
    [No Abstract]   [Full Text] [Related]  

  • 32. Supervision of thrombolysis of acute myocardial infarction using telemedicine.
    Mavrogeni SI; Tsirintani M; Kleanthous C; Vranakis K; Secheta E; Mihelakis D; Sotiriou D; Gatzonis M; Tsolas C; Kontaratos AN; Cokkinos DV
    J Telemed Telecare; 2000; 6(1):54-8. PubMed ID: 10824393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombolytic therapy in acute myocardial infarct. The facts and the statistical ideal].
    Baruzzi AC; Knobel E; Cirenza C; Fehér J
    Arq Bras Cardiol; 1994 Aug; 63(2):87-9. PubMed ID: 7661716
    [No Abstract]   [Full Text] [Related]  

  • 34. Guillain-Barré syndrome after acute myocardial infarction treated with anistreplase.
    Ancillo P; Duarte J; Cortina JJ; Sempere AP; Clavería LE
    Chest; 1994 Apr; 105(4):1301-2. PubMed ID: 8162787
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombolytic therapy also in soon occurring second infarct?].
    Figulla HR
    Dtsch Med Wochenschr; 1992 Nov; 117(47):1819-20. PubMed ID: 1425311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of the extent of infarction on early and late prognosis in patients with acute myocardial infarction].
    Opolski G; Kalotka-Bratek H; Ostrzycki A; Niémczyk M; Korewicki J
    Kardiol Pol; 1987; 30(10-11):632-7. PubMed ID: 3450942
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
    Coppere B; Granade G; Girard-Madoux MH; Claudel JP; Kruszynski G; Porte J; Gayral M; Ninet J
    Presse Med; 1992 Dec; 21(42):2061. PubMed ID: 1294983
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-benefit analysis of thrombolytic therapy.
    Herve C; Castiel D; Gaillard M; Boisvert R; Leroux V
    Eur Heart J; 1990 Nov; 11(11):1006-10. PubMed ID: 2126508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent infarction and extent of infarction in acute myocardial infarct].
    Hasselbalch H; Groth S; Godtfredsen J
    Ugeskr Laeger; 1980 Mar; 142(13):822-4. PubMed ID: 7368369
    [No Abstract]   [Full Text] [Related]  

  • 40. Domiciliary thrombolytic treatment.
    BMJ; 1991 Aug; 303(6799):417-8. PubMed ID: 1912821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.